Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly EBT Margin of 27.06% for Q2 2026, up 6678.0% year-over-year from 0.4% in Q2 2025, and up 3095.27% quarter-over-quarter from 0.9% in Q1 2026.
Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' EBT Margin history runs 15 years deep, the most recent figure standing at 27.06% for Q2 2026.
- In Q2 2026, EBT Margin rose 6678.0% year-over-year to 27.06%; the TTM figure through Jun 2026 stood at 48.19% (up 2380.0% YoY), while the FY2025 annual figure was 72.22%, up 14644.0% from the prior year.
- EBT Margin for Q2 2026 stood at 27.06%, up from 0.9% in the prior quarter.
- The five-year high for EBT Margin was 251.47% in Q4 2025, with the low at 154.99% in Q4 2024.
- The 5-year median for EBT Margin is 58.59% (2022), against an average of 36.59%.
- The sharpest annual moves came in 2025 and 2026: EBT Margin surged 40646 bps in 2025, then plunged 7996 bps in 2026.
- Ptc Therapeutics' EBT Margin stood at 115.48% in 2022, then surged by 31 bps to 80.01% in 2023, then sank by 94 bps to 154.99% in 2024, then surged by 262 bps to 251.47% in 2025, then tumbled by 89 bps to 27.06% in 2026.
- Business Quant data shows PTCT's EBT Margin at 27.06% in Q2 2026, 0.9% in Q1 2026, and 251.47% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 27.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.06% |
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -84.46% |
| Sep 30, 2025 | -10.94% |
| Jun 30, 2025 | -39.72% |
| Mar 31, 2025 | 79.06% |
| Dec 31, 2024 | 236.48% |
| Sep 30, 2024 | -49.80% |
| Mar 31, 2024 | -40.31% |
| Dec 31, 2023 | -80.01% |
| Sep 30, 2023 | -84.75% |
| Jun 30, 2023 | -111.07% |
| Mar 31, 2023 | -61.25% |
| Dec 31, 2022 | -115.48% |
| Sep 30, 2022 | -58.59% |
| Jun 30, 2022 | -89.83% |
| Mar 31, 2022 | -81.95% |
| Dec 31, 2021 | -83.89% |
| Sep 30, 2021 | -96.34% |
| Jun 30, 2021 | -101.03% |